MindChild Medical
MindChild Medical develops and commercializes the MERIDIAN M110, an FDA-cleared non-invasive fetal monitoring system using proprietary abdominal-electrode signal processing to measure fetal heart rate, maternal heart rate, and uterine contractions for hospital labor and delivery units.
- Company typePrivate
- Founded2008
- HeadquartersNorth Andover, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What MindChild Medical does
MindChild Medical, Inc. is a privately held medical device company founded in 2008 and headquartered in North Andover, Massachusetts. The company develops and commercializes the MERIDIAN family of non-invasive fetal monitoring systems, built on exclusively licensed fetal electrocardiograph (fECG) intellectual property from MIT, Tufts Medical Center, and E-TROLZ, Inc. Its core product, the FDA 510(k)-cleared MERIDIAN M110 Fetal Monitoring System, uses abdominal surface electrodes and proprietary digital signal processing algorithms to extract fetal ECG signals and derive fetal heart rate, maternal heart rate, and uterine contraction measurements externally — positioning it as a non-invasive alternative to Doppler, tocometry, fetal scalp electrodes, and intrauterine pressure catheters, particularly for high-BMI obstetric patients where legacy technologies underperform.
The company operates a hardware-plus-consumable business model, selling MERIDIAN M110 capital equipment to hospital labor and delivery units alongside single-use MERIDIAN M110 Disposable Electrode Patches that generate recurring revenue per monitored labor episode. Distribution is conducted through an exclusive supply and distribution agreement with Henry Schein Medical announced in April 2019, supplementing direct sales to healthcare institutions and clinical research deployments. Beyond commercial sales, the technology has been adopted by the Gates Foundation-funded University of North Carolina LABOR Study, where 24 Meridian Fetal Research Devices have been deployed across sites in Zambia, Ghana, and India, generating over 17,970 hours of fECG recordings from 6,000+ subjects.
MindChild is a small organization (1-10 employees) that has self-funded through a series of small disclosed rounds totaling approximately $2.3M since 2010, without identified institutional venture capital backing. The leadership team is composed of clinicians and engineers with deep signal processing and maternal-fetal medicine credentials, including co-founders Adam Wolfberg (MD, Maternal-Fetal Medicine), Gari Clifford (PhD, biomedical signal processing), James Robertson (President/COO), and Jay Ward (Executive Vice President). Regulatory milestones include three FDA 510(k) clearances (2012, 2015, 2017) and ISO 13485:2003 certification (2015).
MindChild Medical firmographics
Firmographics- Name
- MindChild Medical
- Legal name
- MindChild Medical, Inc.
- Website
- https://mindchild.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MindChild Medical develops and commercializes the MERIDIAN M110, an FDA-cleared non-invasive fetal monitoring system using proprietary abdominal-electrode signal processing to measure fetal heart rate, maternal heart rate, and uterine contractions for hospital labor and delivery units.
- Ownership category
- akta.pro rank
MindChild Medical industry classification
Industry- Product category
- Fetal Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)
- akta.pro secondary industry
- Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG)
Keywords
Where MindChild Medical is headquartered
LocationHeadquarters
- HQ city
- North Andover
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MindChild Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of MERIDIAN M110 Fetal Monitoring System hardware to hospitals and healthcare facilities. The device is sold as a capital medical device for labor and delivery units.
- Disposable Electrode Patches: Recurring revenue from disposable electrode patch sets that are used with the MERIDIAN M110 system during labor and delivery procedures.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
MindChild Medical product offering
Product offeringCore offering
MindChild Medical designs, develops, and manufactures the MERIDIAN family of FDA-cleared, non-invasive fetal monitoring devices that externally extract fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA) from abdominal surface electrodes using proprietary fECG signal processing algorithms. The flagship MERIDIAN M110 Fetal Monitoring System, paired with a single-use four-patch disposable electrode array, is sold to hospital labor and delivery units as a capital medical device with recurring disposable revenue. The technology replaces invasive fetal scalp electrodes, intrauterine pressure catheters, Doppler, and TOCO sensors with one non-invasive system that performs equivalently across all patient BMIs.
Product overview
MindChild Medical's product portfolio centers on the MERIDIAN family of non-invasive fetal monitoring devices. The core product is the MERIDIAN M110 Fetal Monitoring System, an FDA-cleared intrapartum monitor that uses abdominal surface electrodes to extract fetal ECG, fetal heart rate, maternal heart rate, and uterine contractions without invasive procedures. Supporting the M110 is a companion product: the MERIDIAN M110 Disposable Electrode Patch, a single-use four-patch system that replaces multiple traditional sensors (fetal scalp electrode, intrauterine pressure catheter, Doppler, and TOCO). The company also offers the MERIDIAN M100 (earlier generation fetal heart monitor) and the M110R research device used in clinical studies. All products share the same underlying technology platform using proprietary signal processing algorithms to extract fetal signals from maternal abdominal electrodes.
Differentiator
Problem solved
Functional benefit
Products and services
- MERIDIAN M110 Fetal Monitoring System FDA-cleared intrapartum fetal monitor that externally measures and displays fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA) using abdominal surface electrodes. The system uses proprietary algorithms to discern between fetal and maternal ECG signals, providing non-invasive monitoring equivalent to gold-standard fetal scalp electrode, and is intended for use by healthcare professionals in clinical settings on women at ≥37 completed weeks, in labor, with singleton pregnancies.
- MERIDIAN M110 Disposable Electrode Patch Single-use electrode patch system consisting of four patches (two for the mother's abdomen and one for each side) that provides continuous fetal signal capture during fetal movement with complete abdominal coverage. It replaces fetal scalp electrode, intrauterine pressure catheter, Doppler, and TOCO sensors with a single non-invasive disposable system, eliminating skin preparation, frequent repositioning, and infection risk.
- MERIDIAN M100 Fetal Heart Monitor Earlier-generation fetal heart monitor using surface electrodes on the maternal abdomen, compatible with existing fetal monitoring systems. The MERIDIAN M100 is designed to provide non-invasive fetal heart rate monitoring and integrates with incumbent hospital fetal monitoring infrastructure.
- Meridian Fetal Research Device (M110R) Research version of the MERIDIAN technology used in clinical studies such as the Gates-funded UNC LABOR Study. Ships with electrode patch sets and is capable of extracting fetal ECG for advanced analytical research including ECG morphology, heart rate variability, and uterine activity in developing-country clinical settings.
Quantifiable outcome
- 96.7% correct fetal heart rate within +/- 5 BPM compared to fetal scalp electrode
- +4 more outcomes
Companies that use MindChild Medical
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
MindChild Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
MindChild Medical partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- UNC LABOR StudycoreGates Foundation-funded research study at University of North Carolina that selected MindChild's Meridian Fetal Research Device as the centerpiece of their study due to its unparalleled ability to accurately extract fetal ECG for advanced analytical research. Dr. Jeffrey Stringer served as Principal Investigator.
- Henry Schein MedicalcoreExclusive distribution and supply agreement for the MERIDIAN M110 Fetal Monitoring System. Henry Schein Medical, as a major medical supplies distributor, provides MindChild Medical access to a broad network of healthcare facilities for the distribution of its fetal monitoring products.
- Oxford UniversityminorSponsored research with Oxford University to develop innovative signal processing software for MERIDIAN Fetal & Maternal Monitor. Gari Clifford, who was faculty at Oxford, contributed to the technology development.
- Massachusetts Institute of TechnologycoreMindChild has exclusively licensed intellectual property from MIT related to fetal ECG monitoring technology.
- Tufts Medical CentercoreMindChild has exclusively licensed intellectual property from Tufts Medical Center related to fetal ECG monitoring technology.
- E-TROLZ, Inc.coreMindChild has exclusively licensed intellectual property from E-TROLZ, Inc., a Massachusetts technology company that develops and commercializes breakthrough physiologic monitoring platforms. E-TROLZ founder James Robertson co-founded MindChild Medical.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
MindChild Medical competitors and assessment
Company assessmentDirect peers
- Edan Instruments: Edan manufactures fetal and maternal monitors (e.g., F series) for global hospital markets. Comparable as an independent medical device company selling non-invasive intrapartum fetal monitors to L&D units.
- Contec Medical Systems: Contec produces a range of patient monitors including fetal/maternal monitors distributed internationally. Comparable as a competing OEM of low-cost fetal monitoring hardware targeting similar hospital customers.
- Neoventa Medical: Neoventa is a fetal monitoring specialist focused on ST analysis of the fetal ECG (STAN). Comparable as a niche player building fECG-based intrapartum monitoring as a differentiated alternative to standard Doppler/toco.
- Huntleigh Healthcare (Arjo): Huntleigh produces bedside fetal/maternal monitors and is a focused niche player in the same clinical segment. Comparable as a smaller specialist competing for the same L&D unit budgets.
Broad incumbents
- Natus Medical: Natus has historically offered obstetric/fetal monitoring products within its broader neuro and newborn care portfolio. Comparable as an incumbent fetal monitoring line from a multi-specialty medtech supplier.
- GE Healthcare: GE Healthcare sells the Corometrics line of fetal monitors and is the dominant installed-base incumbent in U.S. labor and delivery. Comparable as the primary alternative MindChild displaces in hospital L&D units.
- Spacelabs Healthcare (OSI Systems): Spacelabs offers patient monitoring solutions used in hospitals, including perinatal monitoring modules. Comparable as an established multi-parameter monitoring vendor bundling fetal monitoring into broader hospital contracts.
- Philips: Philips offers the Avalon series of fetal and maternal monitors alongside its broader patient monitoring portfolio. It competes head-to-head with MindChild in the intrapartum monitoring market with deep hospital integration and IT connectivity.
Market position
Strengths5 records
Weaknesses5 records
Key risks6 records
Key highlights8 records
Customer concentration
MindChild Medical social profiles
Digital presenceMindChild Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
MindChild Medical leadership team
Management profileNumber of profiles
Profiles7 records
MindChild Medical funding detail
Funding detailFunding overview
Funding rounds8 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MindChild Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MindChild Medical
What does MindChild Medical do?
MindChild Medical designs, develops, and manufactures the MERIDIAN family of FDA-cleared, non-invasive fetal monitoring devices that externally extract fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA) from abdominal surface electrodes using proprietary fECG signal processing algorithms. The flagship MERIDIAN M110 Fetal Monitoring System, paired with a single-use four-patch disposable electrode array, is sold to hospital labor and delivery units as a capital medical device with recurring disposable revenue. The technology replaces invasive fetal scalp electrodes, intrauterine pressure catheters, Doppler, and TOCO sensors with one non-invasive system that performs equivalently across all patient BMIs.
Is MindChild Medical a public or private company?
MindChild Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MindChild Medical founded?
MindChild Medical was founded in 2008. It employs 1 to 10 people.
Where is MindChild Medical based?
MindChild Medical is headquartered in North Andover, United States, in the North America region.
How does MindChild Medical make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are disposable Electrode Patches.
Who are MindChild Medical's main competitors?
Direct peers on record are Edan Instruments, Contec Medical Systems, Neoventa Medical and Huntleigh Healthcare (Arjo). Broad incumbents are Natus Medical, GE Healthcare, Spacelabs Healthcare (OSI Systems) and Philips.
Does MindChild Medical have an API?
No public API is recorded for MindChild Medical.
What industry is MindChild Medical in?
MindChild Medical's product category is Fetal Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLACAPAG, Maternal, Neonatal & Pediatric Remote Monitoring. Its NAICS code is 334510 and its SIC code is 3845.